Inventor · disambiguated record
Christoph Heusser
Also filed as: HEUSSER CHRISTOPH
19 granted patents·10 pending applications·405 citations·filing 1985–2024
95Inventor score
Top patents by PatentIndex Score
29 records- 0196US9221913B2Silent Fc variants of anti-CD40 antibodiesHEUSSER CHRISTOPH·Filed 2014·Granted Dec 29, 2015·35 cites·10 claims
- 0296US8828396B2Silent Fc variants of anti-CD40 antibodiesHEUSSER CHRISTOPH·Filed 2011·Granted Sep 9, 2014·50 cites·6 claims
- 0394US11124578B2Method of treating transplant rejection with silent Fc variants of anti-CD40 antibodiesNOVARTIS AG·Filed 2019·Granted Sep 21, 2021·6 cites·8 claims
- 0491US10899841B2Anti-BAFFR antibody formulations and methods of use thereofNOVARTIS AG·Filed 2019·Granted Jan 26, 2021·3 cites·10 claims
- 0590US8106163B2Compositions and methods of use for therapeutic antibodiesHEUSSER CHRISTOPH·Filed 2009·Granted Jan 31, 2012·18 cites·13 claims
- 0690US5843708AChimeric antibodiesCIBA GEIGY CORP·Filed 1995·Granted Dec 1, 1998·125 cites·21 claims
- 0790US4780401ANovel monoclonal antibodies to human renin and hybridoma cells, processes for their preparation and their applicationsCIBA GEIGY CORP·Filed 1985·Granted Oct 25, 1988·71 cites·13 claims
- 0889US9458240B2Anti-BAFFR antibody formulationsCOSENZA MARTA·Filed 2011·Granted Oct 4, 2016·8 cites·16 claims
- 0987US2025163170A1Antibody formulationNOVARTIS AG·Filed 2024·Application pending·0 cites
- 1087US2024228640A9SILENT Fc VARIANTS OF ANTI-CD40 ANTIBODIESNOVARTIS AG·Filed 2023·Application pending·0 cites
- 1183US9828433B2Nucleic acids encoding silent Fc variants of anti-CD40 antibodiesNOVARTIS AG·Filed 2017·Granted Nov 28, 2017·2 cites·8 claims
- 1282US6020153AChimeric antibodiesCIBA GEIGY CORP·Filed 1994·Granted Feb 1, 2000·68 cites·25 claims
- 1381US9340620B2Compositions and methods of use for therapeutic antibodiesHEUSSER CHRISTOPH·Filed 2011·Granted May 17, 2016·5 cites·5 claims
- 1479US10323096B2Nucleic acids encoding silent Fc variants of anti-CD40 antibodiesNOVARTIS AG·Filed 2017·Granted Jun 18, 2019·1 cites·8 claims
- 1578US8715657B2Therapeutic antibodies binding IL12Rβ1BARDROFF MICHAEL·Filed 2010·Granted May 6, 2014·5 cites·15 claims
- 1678US8574573B2Anti-IL12Rbeta1 antibodies and their use in treating autoimmune and inflammatory disordersCARBALLIDO HERRERA JOSE M·Filed 2011·Granted Nov 5, 2013·5 cites·9 claims
- 1778US2022204635A1SILENT Fc VARIANTS OF ANTI-CD40 ANTIBODIESNOVARTIS AG·Filed 2021·Application pending·0 cites
- 1875US12054555B2Anti-BAFFR antibody formulations and methods of use thereofNOVARTIS AG·Filed 2020·Granted Aug 6, 2024·0 cites·10 claims
- 1975US9688768B2Silent Fc variants of anti-CD40 antibodiesHEUSSER CHRISTOPH·Filed 2015·Granted Jun 27, 2017·1 cites·10 claims
- 2074US9382326B2Compositions and methods of use for therapeutic antibodiesHEUSSER CHRISTOPH·Filed 2011·Granted Jul 5, 2016·2 cites·10 claims
- 2172US2022298251A1Compositions and methods of use for therapeutic antibodiesNOVARTIS AG·Filed 2021·Application pending·0 cites
- 2269US2018179290A1Antibody formulationNOVARTIS AG·Filed 2018·Application pending·0 cites
- 2363US2016368999A1Antibody formulationCOSENZA MARTA·Filed 2016·Application pending·0 cites
- 2460US2019135931A1Compositions and methods of use for therapeutic antibodiesNOVARTIS AG·Filed 2018·Application pending·0 cites
- 2557US8999708B2Anti-IL12Rβ1 antibodies and their use in treating autoimmune and inflammatory disordersCARBALLIDO HERRERA JOSE M·Filed 2013·Granted Apr 7, 2015·0 cites·16 claims
- 2656US8945548B2Anti-IL12Rbeta1 antibodies and their use in treating autoimmune and inflammatory disordersCARBALLIDO HERRERA JOSE M·Filed 2013·Granted Feb 3, 2015·0 cites·11 claims
- 2752US2016347851A1Compositions and methods of use for therapeutic antibodiesHEUSSER CHRISTOPH·Filed 2016·Application pending·0 cites
- 2850US2003073737A1Tolerance inductionFiled 2002·Application pending·0 cites
- 2947US2014248265A1Therapeutic antibodies binding il 12rbeta1BARDROFF MICHAEL OTTO·Filed 2014·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Christoph Heusser files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →